Allele frequency of CYP2C9 gene polymorphisms in Iran. - Suppr | 超能文献

Allele frequency of CYP2C9 gene polymorphisms in Iran.

作者信息

Peyvandi F, Spreafico M, Karimi M, Zeinali S, Mannucci P M, Bianchi Bonomi A

出版信息

Thromb Haemost. 2002 Nov;88(5):874-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Allele frequency of CYP2C9 gene polymorphisms in Iran.

Thromb Haemost. 2002 Nov;88(5):874-5.

2

Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).伊朗人群（马赞德兰省）中CYP2C9的等位基因和基因型频率。

Genet Test Mol Biomarkers. 2012 Jul;16(7):817-21. doi: 10.1089/gtmb.2011.0301. Epub 2012 Jan 30.

3

Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.性别以及CYP2C9和CYP2C8基因多态性对布洛芬对映体药代动力学的影响。

Pharmacogenomics. 2015;16(9):939-48. doi: 10.2217/pgs.15.40. Epub 2015 Jun 30.

4

The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.OATP1B1基因中的Asn130Asp和Val174Ala多态性以及CYP2C9等位基因*3独立影响托拉塞米的药代动力学和药效学。

Clin Pharmacol Ther. 2008 Jun;83(6):815-7. doi: 10.1038/sj.clpt.6100404. Epub 2007 Nov 14.

5

Distribution of CYP2C polymorphisms in an Amerindian population of Brazil.巴西一个美洲印第安人群体中CYP2C基因多态性的分布。

Basic Clin Pharmacol Toxicol. 2012 Apr;110(4):396-400. doi: 10.1111/j.1742-7843.2011.00807.x. Epub 2011 Nov 4.

6

Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations.CYP2C9 2 和 CYP2C9 3 多态性在六个墨西哥人群中的等位基因频率分布。

Gene. 2013 Jul 10;523(2):167-72. doi: 10.1016/j.gene.2013.03.128. Epub 2013 Apr 12.

7

Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.与CYP2C9基因多态性相关的Δ9-四氢大麻酚药代动力学的个体间差异。

Clin Pharmacol Ther. 2009 Mar;85(3):273-6. doi: 10.1038/clpt.2008.213. Epub 2008 Nov 12.

8

Effects of CYP2C9 polymorphisms on phenprocoumon anticoagulation status.

Clin Pharmacol Ther. 2005 Apr;77(4):335-6; author reply 336. doi: 10.1016/j.clpt.2005.01.012.

9

No exon 4 polymorphism of cytochrome P450 CYP2C9 in Taiwanese.台湾人群中细胞色素P450 CYP2C9第4外显子无多态性。

Blood. 2003 Jun 15;101(12):5086-7. doi: 10.1182/blood-2003-02-0467.

10

Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.细胞色素P450 2C9基因多态性对苯丙香豆素抗凝状态的影响。

Clin Pharmacol Ther. 2004 Nov;76(5):409-17. doi: 10.1016/j.clpt.2004.08.006.

引用本文的文献

1

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.CYP2C9 和 CYP2C19 基因多态性对印度癫痫患者苯妥英钠诱导的神经毒性的影响。

Eur J Clin Pharmacol. 2010 Jul;66(7):689-96. doi: 10.1007/s00228-010-0817-2.

2

Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects.氯沙坦及其活性代谢物EXP3174在伊朗健康受试者中的药代动力学

Clin Drug Investig. 2004;24(10):619-23. doi: 10.2165/00044011-200424100-00008.

3

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.健康个体中CYP2C8和CYP2C9基因多态性的种族间及种族内变异性。

Mol Diagn Ther. 2006;10(1):29-40. doi: 10.1007/BF03256440.